Grants and Contributions:
Title:
Late Stage Development of a One Minute Hepatitis C Virus Diagnostic Test
Agreement Number:
947712
Agreement Value:
$290,000.00
Agreement Date:
Apr 1, 2020 - Jun 30, 2021
Description:
This project will complete the late stages of development and analytical validation of a one-minute rapid point of care diagnostic test designed to detect hepatitis C virus (HCV) antibodies from human blood, plasma and serum in preparation for clinical trials and regulatory submission.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Richmond, British Columbia, CA V6V 2A2
Reference Number:
172-2020-2021-Q1-947712
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
869859116
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 107 days. The total amended value is 10,000 dollars.
Amendment Date
Mar 8, 2021
Recipient's Legal Name:
BioLytical Laboratories Inc.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: